Pacira BioSciences, Inc. provided earnings guidance for the year 2024. For the year, the company expects total revenue of $680 million to $705 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.33 USD | -0.43% | +2.16% | -10.11% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.11% | 1.41B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Pacira BioSciences, Inc. Provides Earnings Guidance for the Year 2024